Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Analgesia, Epidural | 5 | 2020 | 102 | 1.310 |
Why?
|
| Pain Management | 4 | 2021 | 668 | 0.980 |
Why?
|
| Recovery of Function | 4 | 2018 | 703 | 0.750 |
Why?
|
| Anesthesia, Epidural | 1 | 2020 | 31 | 0.730 |
Why?
|
| Delivery of Health Care | 2 | 2018 | 860 | 0.670 |
Why?
|
| Spinal Diseases | 1 | 2018 | 125 | 0.620 |
Why?
|
| Cost Savings | 1 | 2018 | 123 | 0.610 |
Why?
|
| Pain, Postoperative | 6 | 2021 | 610 | 0.520 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2018 | 261 | 0.490 |
Why?
|
| Analgesics, Opioid | 3 | 2023 | 1371 | 0.460 |
Why?
|
| Health Care Costs | 1 | 2018 | 674 | 0.450 |
Why?
|
| Length of Stay | 2 | 2018 | 1900 | 0.430 |
Why?
|
| Critical Care | 1 | 2018 | 770 | 0.420 |
Why?
|
| Hematoma, Epidural, Spinal | 2 | 2020 | 16 | 0.350 |
Why?
|
| Patient Care Team | 1 | 2013 | 795 | 0.320 |
Why?
|
| Postoperative Period | 3 | 2018 | 665 | 0.290 |
Why?
|
| Craniotomy | 2 | 2018 | 304 | 0.250 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2016 | 209 | 0.250 |
Why?
|
| Thoracotomy | 2 | 2016 | 220 | 0.240 |
Why?
|
| Amputees | 1 | 2023 | 18 | 0.230 |
Why?
|
| Epidural Space | 1 | 2020 | 42 | 0.190 |
Why?
|
| Chronic Pain | 1 | 2023 | 238 | 0.180 |
Why?
|
| Catheters | 1 | 2020 | 126 | 0.170 |
Why?
|
| Retrospective Studies | 11 | 2023 | 37905 | 0.170 |
Why?
|
| Anesthesia | 1 | 2021 | 296 | 0.160 |
Why?
|
| Lidocaine | 1 | 2017 | 76 | 0.150 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2017 | 59 | 0.150 |
Why?
|
| Anesthetics, Local | 1 | 2018 | 163 | 0.140 |
Why?
|
| Heparin | 1 | 2018 | 360 | 0.140 |
Why?
|
| Time Factors | 5 | 2018 | 12926 | 0.140 |
Why?
|
| Nerve Block | 1 | 2018 | 176 | 0.140 |
Why?
|
| Neoplasms | 4 | 2019 | 15193 | 0.140 |
Why?
|
| Brain Neoplasms | 3 | 2018 | 4849 | 0.130 |
Why?
|
| Monitoring, Intraoperative | 1 | 2017 | 264 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2017 | 305 | 0.130 |
Why?
|
| Spinal Cord Compression | 1 | 2016 | 151 | 0.130 |
Why?
|
| Perioperative Care | 2 | 2021 | 451 | 0.120 |
Why?
|
| Analgesics | 1 | 2017 | 390 | 0.120 |
Why?
|
| Postoperative Complications | 3 | 2019 | 5542 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2017 | 739 | 0.110 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2017 | 690 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2018 | 787 | 0.110 |
Why?
|
| Laser Therapy | 1 | 2016 | 411 | 0.110 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 609 | 0.110 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 904 | 0.100 |
Why?
|
| Spinal Neoplasms | 1 | 2016 | 631 | 0.100 |
Why?
|
| Self Report | 1 | 2015 | 756 | 0.100 |
Why?
|
| Hepatectomy | 1 | 2017 | 1011 | 0.100 |
Why?
|
| Humans | 18 | 2023 | 261506 | 0.090 |
Why?
|
| Aged | 10 | 2019 | 70117 | 0.090 |
Why?
|
| Cost of Illness | 1 | 2013 | 498 | 0.090 |
Why?
|
| Pneumonectomy | 1 | 2015 | 831 | 0.090 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 29902 | 0.080 |
Why?
|
| Global Health | 1 | 2013 | 657 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 5319 | 0.080 |
Why?
|
| Male | 10 | 2018 | 123000 | 0.070 |
Why?
|
| Middle Aged | 10 | 2019 | 86204 | 0.070 |
Why?
|
| Female | 11 | 2018 | 141928 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2017 | 1797 | 0.070 |
Why?
|
| Adult | 8 | 2019 | 77950 | 0.060 |
Why?
|
| Aging | 1 | 2013 | 1582 | 0.060 |
Why?
|
| Rosaniline Dyes | 1 | 2004 | 108 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 11538 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2023 | 159 | 0.050 |
Why?
|
| Muscles | 1 | 2023 | 416 | 0.050 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2017 | 799 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 1945 | 0.050 |
Why?
|
| Incidence | 2 | 2020 | 5673 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2018 | 334 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2018 | 257 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2017 | 12873 | 0.040 |
Why?
|
| Scalp | 1 | 2018 | 156 | 0.040 |
Why?
|
| Stereotaxic Techniques | 1 | 2016 | 172 | 0.030 |
Why?
|
| Decompression, Surgical | 1 | 2016 | 143 | 0.030 |
Why?
|
| Texas | 2 | 2018 | 6311 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2016 | 96 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2018 | 10001 | 0.030 |
Why?
|
| Young Adult | 3 | 2019 | 21445 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 1382 | 0.030 |
Why?
|
| Risk Factors | 3 | 2018 | 17523 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 3472 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 1688 | 0.030 |
Why?
|
| Hyperthermia, Induced | 1 | 2016 | 510 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 14889 | 0.030 |
Why?
|
| Health Status | 1 | 2015 | 590 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2018 | 32848 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 925 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2015 | 953 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 4298 | 0.020 |
Why?
|
| Adolescent | 3 | 2019 | 31252 | 0.020 |
Why?
|
| Liver | 1 | 2020 | 2961 | 0.020 |
Why?
|
| Comorbidity | 1 | 2015 | 2352 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6207 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 4971 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2019 | 16273 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2017 | 4078 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 4892 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 5047 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 6869 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 9244 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 4320 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2004 | 246 | 0.020 |
Why?
|
| Injections | 1 | 2004 | 285 | 0.010 |
Why?
|
| Quality of Life | 1 | 2016 | 4532 | 0.010 |
Why?
|
| Child | 2 | 2019 | 29154 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 14551 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 13658 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 21713 | 0.010 |
Why?
|